Drug abuse continues to be a major public health problem worldwide, with over 1.5 million Americans confirming current cocaine use and, at present, there are no FDA-approved treatments for cocaine addiction. This research project is a continuation of funded work aimed at understanding the neurobiology of cocaine abuse in a unique nonhuman primate model: intravenous cocaine self-administration in socially housed cynomolgus monkeys. The goals of the present application are to continue using this homologous animal model to examine the mechanisms of action mediating the interactions between social hierarchy and environmental and pharmacological modulation of drug self-administration in female and male monkeys. Over the previous funding period, we have noted sex- and social-rank related differences in vulnerability to cocaine self-administration (SA) and in response to several acute pharmacological manipulations.
In Aim 1, we will extend this characterization to chronic drug treatment in socially housed monkeys self-administering cocaine in the context of an alternative, non-drug, reinforcer (food-cocaine choice). We will also examine how these treatments affect cocaine-induced reinstatement. The studies in Aim 2 will extend these sex- and social-rank differences to impulsive-like behavior by implementing delays to food and cocaine. When food is delayed, we hypothesize that females will be more ?impulsive? compared to males and when cocaine is delayed, subordinates will require longer delays to shift preference. The effects of long-term cocaine SA and chronic drug treatment on cognitive performance in socially housed monkeys will be examined in Aim 3. We hypothesize that cognitive performance of females will be more disrupted by cocaine than performance by males and that subordinate monkeys will be more sensitive than dominant animals. Recently, we reported social-rank related differences in brain glucose utilization using [18F]fluorodeoxyglucose and PET and in dopamine D2/D3 receptor availability using [11C]raclopride. The goal of Aim 4 is to examine how cocaine SA and chronic drug treatment differentially affects glucose utilization and D2/D3 receptor availability in socially housed female and male monkeys. The scientific premise is that different mechanisms maintain cocaine SA based on social rank and sex and thus different drugs will be required to produce a positive outcome in these groups. We are proposing a preclinical personalized-medicine strategy for treating drug abuse that incorporates sex and social variables. Results from these studies should aid in the development of novel and individualized treatment strategies for drug addiction.

Public Health Relevance

Individual differences, social factors and sex are variables that influence vulnerability, maintenance and treatment outcome in human drug addiction. The research proposed in this application will further explore behavioral (cocaine self-administration, impulsive choice, cognition), pharmacological (chronic drug treatments) and brain changes using positron emission tomography in socially housed female and male monkeys. Results from these studies should aid in the development of personalized medicine strategies for drug addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA017763-13
Application #
9982843
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Moore, Holly Marie
Project Start
2004-05-01
Project End
2023-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Physiology
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Nader, Michael A (2016) Animal models for addiction medicine: From vulnerable phenotypes to addicted individuals. Prog Brain Res 224:3-24
Czoty, Paul W; Stoops, William W; Rush, Craig R (2016) Evaluation of the ""Pipeline"" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research. Pharmacol Rev 68:533-62
Heilig, Markus; Epstein, David H; Nader, Michael A et al. (2016) Time to connect: bringing social context into addiction neuroscience. Nat Rev Neurosci 17:592-9
Kromrey, Sarah A; Gould, Robert W; Nader, Michael A et al. (2015) Effects of prior cocaine self-administration on cognitive performance in female cynomolgus monkeys. Psychopharmacology (Berl) 232:2007-16
Kromrey, Sarah A; Czoty, Paul W; Nader, Michael A (2015) Relationship between estradiol and progesterone concentrations and cognitive performance in normally cycling female cynomolgus monkeys. Horm Behav 72:12-9
Nader, Michael A; Banks, Matthew L (2014) Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging. Neuropharmacology 76 Pt B:510-7
Gould, Robert W; Duke, Angela N; Nader, Michael A (2014) PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations. Neuropharmacology 84:138-51
Nader, Michael A; Balster, Robert L; Henningfield, Jack E (2014) William L. Woolverton: a case history in unraveling the behavioral pharmacology of stimulants. Neuropharmacology 87:4-8
Gould, Robert W; Porrino, Linda J; Nader, Michael A (2012) Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation. Curr Top Behav Neurosci 11:25-44
Nader, Michael A; Czoty, Paul W; Nader, Susan H et al. (2012) Nonhuman primate models of social behavior and cocaine abuse. Psychopharmacology (Berl) 224:57-67

Showing the most recent 10 out of 17 publications